Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function
- 13 January 2015
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 33 (3), 1465-1474
- https://doi.org/10.3892/or.2015.3712
Abstract
Glioblastoma multiforme (GBM) is one of the most common encephalic malignant tumors. Due to a high recurrence rate and a lack of effective treatments, the average survival rate remains low. Temozolomide (TMZ), a class of alkylating agent, is widely used as a first-line therapeutic drug during the adjuvant treatment for GBM patients. However, most patients exhibit a palpable resistance to TMZ treatment. Additionally, the underlying mechanism remains to be clarified. In this study, glutathione (GSH) and reactive oxygen species (ROS) levels were found to be closely associated with the sensitivity of GBM cells to TMZ. We also found that TMZ markedly induced xCT, the subunit of glutamate/cystine transporter system xc- expression, which together with the GSH synthesis was increased while the TMZ-inducible ROS level was decreased in GBM cells. In addition, the cystathionine γ-lyase (CTH) acivity, a key enzyme in the transsulfuration pathway was enhanced by TMZ, which insured a cysteine supply and GSH synthesis in a compensatory manner when xCT was blocked. Thus, the individual inhibition of xCT by siRNA and a pharmacological inhibitor (sulfasalazine) only partially inhibited GSH synthesis and moderately enhanced the GBM cell sensitivity to TMZ. However, the TMZ‑induced cytotoxicity was markedly increased along with a marked decrease in GSH levels as result of co-treatment with erastin, which inhibited cysteine uptake from xCT transporter and suppressed CTH activity, leading to impaired transformation from methionine to cysteine. In conclusion, to GBM therapy with a drug combination of TMZ and erastin may be beneficial.Keywords
This publication has 45 references indexed in Scilit:
- Nrf2- and ATF4-Dependent Upregulation of xCT Modulates the Sensitivity of T24 Bladder Carcinoma Cells to Proteasome InhibitionMolecular and Cellular Biology, 2014
- Glutathione synthesisBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- The oxidative stress-inducible cystine/glutamate antiporter, system x c − : cystine supplier and beyondAmino Acids, 2011
- Molecular targets of glioma invasionCellular and Molecular Life Sciences, 2007
- MGMTGene Silencing and Benefit from Temozolomide in GlioblastomaNew England Journal of Medicine, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Years of life lost (YLL) from cancer is an important measure of population burden — and should be considered when allocating research fundsBritish Journal of Cancer, 2005
- Role of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell linesBritish Journal of Cancer, 2003
- Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroidsBritish Journal of Cancer, 2003
- Cloning and Expression of a Plasma Membrane Cystine/Glutamate Exchange Transporter Composed of Two Distinct ProteinsJournal of Biological Chemistry, 1999